FridayApr 26, 2024 10:00 am

Researchers Seek to Develop Genetically Engineered Brain Cancer Treatment

Scientists at Purdue University are trying to develop a new treatment for glioblastoma tumors. Glioblastoma is a type of cancer that originates in the spinal cord and/or brain. This cancer is fatal, with a median time of survival of 14 months. Conventional treatments for other cancers, including immunotherapy and chemotherapy, are ineffective on this particular cancer. These treatments work by blood cells being taken from a patient then reintroduced back into their bodies after genetic engineering to fight cancer cells. This study was led by associate professor Sandro Matosevic of Purdue’s department of industrial and molecular pharmaceutics. The study’s objective…

Continue Reading

WednesdayApr 24, 2024 12:00 pm

“Urgent Action: PaxMedica Inc. (NASDAQ: PXMD) Addresses Medical Crisis in Malawi”

In recent developments, PaxMedica (NASDAQ: PXMD), a renowned biopharmaceutical company specializing in treatments for neurological disorders, has taken swift action to address a pressing medical situation unfolding in Malawi, East Africa. The Ministry of Health (“MOH”) of Malawi has issued a plea for access to IV suramin, a vital medication in combating the life-threatening sleeping sickness crisis affecting the region. PaxMedica swiftly responded to this call for help by committing to provide emergency access to its recently completed registration batches of PAX-101, an IV form of suramin. This decision underscores PaxMedica's dedication to mitigating the devastating impact of sleeping sickness…

Continue Reading

WednesdayApr 24, 2024 10:00 am

Advancements in Medical AI Are Improving Timely Esophageal Cancer Detection

Scientists in China recently identified an innovative system that considerably increases the rate of detection of esophageal cancer lesions. Esophageal cancer starts from the esophagus, which ferries food from the throat to the stomach. Early detection of this particular cancer is crucial as rates of survival considerably increase when the illness is identified and treated in its early stages. Unfortunately, this cancer is often diagnosed in its later stages when patients begin presenting with symptoms, which makes treatment more difficult. So, how does artificial intelligence improve esophageal cancer detection? Artificial intelligence analyzes endoscopic images using advanced algorithms to identify lesions…

Continue Reading

TuesdayApr 23, 2024 9:45 am

Nutriband Inc. (NASDAQ: NTRB) Advances Abuse Deterrent Tech Addressing Fentanyl Epidemic

Fentanyl is a potent opioid that is associated with a significant risk of abuse and overdose, contributing to a major drug crisis in the United States Fentanyl has legitimate medical uses in managing severe and chronic pain in medical settings such as hospitals and surgical procedures NTRB is advancing its AVERSA(TM) technology that incorporates aversive agents to prevent abuse, diversion, misuse, and accidental exposure to opioids and other drugs with abuse potential NTRB was recently granted a patent for AVERSA(TM), strengthening its intellectual property portfolio in the United States and globally across 45 countries Fentanyl, a potent opioid, poses a…

Continue Reading

MondayApr 22, 2024 10:30 am

Clene Inc. (NASDAQ: CLNN) Continues Development of Lead Drug Candidate CNM Au8(R) for Neurodegenerative Diseases including Parkinson’s Disease

CNM-Au8 is an oral suspension with demonstrated activity in restoring neuronal health and function by increasing energy production and utilization Treatment with CNM-Au8 investigated in clinical trials adjunctive to standard-of-care exhibits no known drug interactions, and aims to enhance function and survival Nearly 90,000 people are diagnosed with Parkinson's disease every year with no approved drug to slow or halt disease progression currently available The Parkinson's disease treatment market was valued at $4.61 billion in 2022 and is expected to reach $11.98 billion by 2030 In recognition of April as Parkinson’s Disease Awareness Month, IBN is highlighting Clene (NASDAQ: CLNN),…

Continue Reading

MondayApr 22, 2024 10:00 am

CMS Completes New Rules Modifying Medicare Advantage Program

Earlier this month, the Centers for Medicare and Medicaid Services (CMS) published a regulation implementing changes in policy to Medicare Part C and Part D. The changes expand on policies under the Biden-Harris administration to promote healthy competition, strengthen guardrails and protections, and ensure Medicare Part D plans meet the needs of all who enroll. The changes in policy include restrictions on beneficiary data distribution, revisions on compensation rules for brokers and agents who hinder anticompetitive steering, and improvements to behavioral health access. We look at them in detail below. Limitations on beneficiary data distribution by third-party marketing organizations The…

Continue Reading

FridayApr 19, 2024 10:00 am

Misinformation on TikTok Causing Many to Misdiagnose Themselves as Autistic

As the global youth population increases its use of social media, misinformation continues to be a danger to many. Joseph O’Brien, a manager at Inspira Health’s Behavioral Wellness Center, stated that social media had increased the dangers of self-diagnosis. Social media apps such as TikTok are already used to spread misinformation, particularly on developmental and mental-health conditions. Various posts include individuals sharing their self-diagnosis of conditions such as autism spectrum disorder despite mental-health professionals on the same TikTok platform highlighting the importance of getting diagnosed by a licensed medical provider. A recent study by the A.J. Drexel Autism Institute determined…

Continue Reading

WednesdayApr 17, 2024 10:00 am

New Study Shows Social Isolation, Frailty Worsen Health Risks for Aging People

A recently published review has found that social vulnerability and frailty worsen as individuals age. When both are present, these conditions result in a considerably heightened decline in cognitive and physical function as well as mortality risk. So, what is frailty? Theoretically, frailty is defined as a state of heightened vulnerability resulting from declines associated with age that is clinically recognizable. These declines often compromise an individual’s ability to cope with acute stressors, with researchers noting that frailty is common among older people. While advancements in modern medicine have significantly improved life expectancy of humans beyond natural limits, frailty remains…

Continue Reading

TuesdayApr 16, 2024 9:45 am

Astiva Health Inc. Committed to Creating Healthcare Model Focused on Collaboration Between Physician and Patient

Duke reports that physician-patient relationships can have profound positive and negative implications on clinical care” The dynamic between a physician and patient can be impacted by the ability to speak articulately, including the knowledge of a foreign language, and racial and cultural differences Astiva Health specializes in innovative health plans tailored to meet the unique requirements of its members Astiva Health has a network of providers that closely matches patients’ demographic background, interest, language and culture. This does not come by luck. Astiva has always been working on improving its provider network and physician-patient assignment, ensuring health plans align with client…

Continue Reading

MondayApr 15, 2024 10:00 am

Study Identifies Three Distinct Subtypes of Multiple Sclerosis

Multiple sclerosis (MS) is a chronic illness that affects an individual’s central nervous system. The disease manifests differently in each individual and has varying trajectories, which makes it difficult to manage. It also has no cure. New research has identified three subtypes of the disease based on immune markers observed in participants’ blood. For the research, a team of investigators led by Professor Heinz Wiendl, a professor at the University of Münster, conducted a comprehensive analysis of the immunological properties of different blood samples collected from more than 300 early multiple sclerosis patients and a validation group made up of…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050